Status:
NOT_YET_RECRUITING
Efficacy of Cryotherapy in Managing Chemotherapy-Induced Peripheral Neuropathy in Children With Leukemia
Lead Sponsor:
Delta University for Science and Technology
Conditions:
Cancer
Eligibility:
All Genders
8-17 years
Phase:
NA
Brief Summary
This study aimed to assess the efficacy of cryotherapy in controlling Peripheral Neuropathy in cancer children
Detailed Description
Peripheral neuropathy is a serious condition characterized by symmetrical, distal damage to the peripheral nerves that may be caused by several classes of drugs, including chemotherapeutic agents. Che...
Eligibility Criteria
Inclusion
- Their age will ranging from eight to seventeen years.
- Children participated in this study will from both sexes.
- Children receiving chemotherapy as medical treatment protocol
- All children have polyneuropathy caused by chemotherapy.
Exclusion
- Children with Epilepsy.
- Children with blood clotting disorder.
- Children have Open wounds / broken skin
- Children with severe cardiac disease
- Uncooperative patients.
Key Trial Info
Start Date :
September 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06543264
Start Date
September 1 2024
End Date
January 1 2025
Last Update
August 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Valley University, Faculty of Physical Therapy
Qina, Egypt, 83523